Position in NVAX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$563,928
+$41,861 QoQ
Shares Held
59,865
-6.7% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#87
of 263 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vontobel Holding Ltd. holds $98,796,822 across 44 Biotechnology names. NVAX ranks #17 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
81,525 | $40,495,910 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
33,169 | $20,682,197 | |
| 3 | MRNA |
Moderna, Inc.
|
87,541 | $6,130,496 | |
| 4 | BNTX |
BioNTech SE
|
61,238 | $5,698,195 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
153,242 | $4,018,005 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
35,363 | $2,633,836 | |
| 7 | TARS |
Tarsus Pharmaceuticals, Inc.
|
40,000 | $2,517,600 | |
| 8 | SLS |
SELLAS Life Sciences Group, Inc.
|
146,762 | $2,166,207 |
All Filings in NVAX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $563,928 | 59,865 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $522,067 | 64,136 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $671,684 | 99,953 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $539,560 | 62,233 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $483,342 | 76,721 | Shares | Defined | 2025-07-23 | |
| 2025-03-31 | $486,006 | 75,820 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $3,463,125 | 430,737 | Shares | Defined | 2025-01-30 | |
| 2024-09-30 | $6,296,459 | 498,532 | Shares | Defined | 2024-10-16 | |
| 2024-06-30 | $3,001,280 | 237,068 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,236,734 | 258,731 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $999,940 | 208,321 | Shares | Defined | 2024-06-04 | |
| 2023-09-30 | $1,549,106 | 213,965 | Shares | Defined | 2024-06-04 | |
| 2023-06-30 | $642,449 | 86,467 | Shares | Defined | 2024-06-04 | |
| 2023-03-31 | $1,174,115 | 169,425 | Shares | Defined | 2024-06-04 | |
| 2022-12-31 | $955,012 | 92,900 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,711,983 | 94,065 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $2,788,841 | 54,226 | Shares | Defined | 2022-07-27 | |
| 2022-03-31 | $2,892,307 | 39,271 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,450,418 | 24,117 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,953,193 | 19,069 | Shares | Defined | 2021-10-29 | |
| 2021-06-30 | $3,050,044 | 14,366 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $4,409,459 | 24,320 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $1,908,159 | 17,112 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||